Cancer Research Versailles No Abst Frontiers in Basic Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van de Sande, T.
Right arrow Articles by Swinnen, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van de Sande, T.
Right arrow Articles by Swinnen, J. V.
[Cancer Research 62, 642-646, February 1, 2002]
© 2002 American Association for Cancer Research

Advances in Brief

Role of the Phosphatidylinositol 3'-Kinase/PTEN/Akt Kinase Pathway in the Overexpression of Fatty Acid Synthase in LNCaP Prostate Cancer Cells1

Tine Van de Sande, Ellen De Schrijver, Walter Heyns, Guido Verhoeven and Johannes V. Swinnen2

Laboratory for Experimental Medicine and Endocrinology, Gasthuisberg, Catholic University of Leuven, B-3000 Leuven, Belgium

One of the most common molecular changes in cancer cells is the overexpression of fatty acid synthase (FAS), a key metabolic enzyme catalyzing the terminal steps in the synthesis of long chain saturated fatty acids. As part of our efforts to elucidate the mechanisms responsible for FAS overexpression, we have addressed the question whether overexpression of FAS may be linked to the frequently observed inactivation of PTEN and subsequent activation of the phosphatidylinositol 3'-kinase (PI3k) pathway . Using LNCaP prostate cancer cells as an experimental paradigm of FAS-overexpressing PTEN-null cancer cells, we demonstrate that LY294002, an inhibitor of the PI3k pathway causes a dramatic decrease in FAS protein expression. Smaller but still substantial effects are seen at the FAS mRNA level and at the level of transcriptional activity of FAS promoter-reporter constructs. Consistent with these findings, reintroduction of PTEN results in decreased levels of FAS expression in a manner that is dependent on its lipid phosphatase activity. In support of a role for Akt/protein kinase B as a downstream effector, cotransfection of constitutively active Akt1/protein kinase B {alpha} abrogates the inhibitory effects of PTEN expression and restores FAS promoter activity. Taken together, these results demonstrate that inactivation of PTEN and subsequent activation of the PI3k/Akt kinase pathway may play an important role in the overexpression of the FAS protein in cancer cells.




This article has been cited by other articles:


Home page
 Molecular Cancer TherapeuticsHome page
J. L. Little, F. B. Wheeler, C. Koumenis, and S. J. Kridel
Disruption of crosstalk between the fatty acid synthesis and proteasome pathways enhances unfolded protein response signaling and cell death
Mol. Cancer Ther., December 1, 2008; 7(12): 3816 - 3824.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
C. Plathow and W. A. Weber
Tumor Cell Metabolism Imaging
J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
R. Xiao, Y. Su, R. C. M. Simmen, and F. A. Simmen
Dietary soy protein inhibits DNA damage and cell survival of colon epithelial cells through attenuated expression of fatty acid synthase
Am J Physiol Gastrointest Liver Physiol, April 1, 2008; 294(4): G868 - G876.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. Furuta, S. K. Pai, R. Zhan, S. Bandyopadhyay, M. Watabe, Y.-Y. Mo, S. Hirota, S. Hosobe, T. Tsukada, K. Miura, et al.
Fatty Acid Synthase Gene Is Up-regulated by Hypoxia via Activation of Akt and Sterol Regulatory Element Binding Protein-1
Cancer Res., February 15, 2008; 68(4): 1003 - 1011.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
P. S. Hegde, D. Rusnak, M. Bertiaux, K. Alligood, J. Strum, R. Gagnon, and T. M. Gilmer
Delineation of molecular mechanisms of sensitivity to lapatinib in breast cancer cell lines using global gene expression profiles
Mol. Cancer Ther., May 1, 2007; 6(5): 1629 - 1640.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
W. Zhou, W. F. Han, L. E. Landree, J. N. Thupari, M. L. Pinn, T. Bililign, E. K. Kim, A. Vadlamudi, S. M. Medghalchi, R. El Meskini, et al.
Fatty Acid Synthase Inhibition Activates AMP-Activated Protein Kinase in SKOV3 Human Ovarian Cancer Cells
Cancer Res., April 1, 2007; 67(7): 2964 - 2971.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. J. DeBerardinis, J. J. Lum, and C. B. Thompson
Phosphatidylinositol 3-Kinase-dependent Modulation of Carnitine Palmitoyltransferase 1A Expression Regulates Lipid Metabolism during Hematopoietic Cell Growth
J. Biol. Chem., December 8, 2006; 281(49): 37372 - 37380.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
H. Cheng, R. Snoek, F. Ghaidi, M. E. Cox, and P. S. Rennie
Short Hairpin RNA Knockdown of the Androgen Receptor Attenuates Ligand-Independent Activation and Delays Tumor Progression
Cancer Res., November 1, 2006; 66(21): 10613 - 10620.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
R. Lupu and J. A. Menendez
Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?
Endocrinology, September 1, 2006; 147(9): 4056 - 4066.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. P. Kuhajda
Fatty Acid synthase and cancer: new application of an old pathway.
Cancer Res., June 15, 2006; 66(12): 5977 - 5980.
[Abstract] [Full Text] [PDF]

Home page
 Molecular Cancer TherapeuticsHome page
X. Liu, Y. Shi, V. L. Giranda, and Y. Luo
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway sensitizes MDA-MB468 human breast cancer cells to cerulenin-induced apoptosis.
Mol. Cancer Ther., March 1, 2006; 5(3): 494 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
Z Culig, H Steiner, G Bartsch, and A Hobisch
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
Endocr. Relat. Cancer, June 1, 2005; 12(2): 229 - 244.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Brusselmans, R. Vrolix, G. Verhoeven, and J. V. Swinnen
Induction of Cancer Cell Apoptosis by Flavonoids Is Associated with Their Ability to Inhibit Fatty Acid Synthase Activity
J. Biol. Chem., February 18, 2005; 280(7): 5636 - 5645.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Maeda, S. Nagata, C. D. Wolfgang, G. L. Bratthauer, T. K. Bera, and I. Pastan
The T Cell Receptor {gamma} Chain Alternate Reading Frame Protein (TARP), a Prostate-specific Protein Localized in Mitochondria
J. Biol. Chem., June 4, 2004; 279(23): 24561 - 24568.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
Y. Li, J. Webster-Cyriaque, C. C. Tomlinson, M. Yohe, and S. Kenney
Fatty Acid Synthase Expression Is Induced by the Epstein-Barr Virus Immediate-Early Protein BRLF1 and Is Required for Lytic Viral Gene Expression
J. Virol., April 15, 2004; 78(8): 4197 - 4206.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. J. Kridel, F. Axelrod, N. Rozenkrantz, and J. W. Smith
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
Cancer Res., March 15, 2004; 64(6): 2070 - 2075.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
S. Rossi, E. Graner, P. Febbo, L. Weinstein, N. Bhattacharya, T. Onody, G. Bubley, S. Balk, and M. Loda
Fatty Acid Synthase Expression Defines Distinct Molecular Signatures in Prostate Cancer
Mol. Cancer Res., August 1, 2003; 1(10): 707 - 715.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. De Schrijver, K. Brusselmans, W. Heyns, G. Verhoeven, and J. V. Swinnen
RNA Interference-mediated Silencing of the Fatty Acid Synthase Gene Attenuates Growth and Induces Morphological Changes and Apoptosis of LNCaP Prostate Cancer Cells
Cancer Res., July 1, 2003; 63(13): 3799 - 3804.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
F. D. Camassei, R. Cozza, A. Acquaviva, A. Jenkner, L. Rava, R. Gareri, A. Donfrancesco, C. Bosman, P. Vadala, T. Hadjistilianou, et al.
Expression of the Lipogenic Enzyme Fatty Acid Synthase (FAS) in Retinoblastoma and Its Correlation with Tumor Aggressiveness
Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2399 - 2403.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.